<< Return to Courses Dr. David Urion discusses the neurologic, cognitive, and psychologic consequences of COVID-19 in children. Dr. Urion also discusses the sources of excess mortality and morbidity of COVID-19 infections in the US. The presentation was recorded at the Holy Family Summit 2022 on June 1, 2022.
Associate, Department of Neurology; Charles F. Barlow Chair in Neurology; Director, Education; Associate Director, Child Neurology and Neurodevelopmental Disabilities Residency Training Programs; Director, Behavioral Neurology Clinics and Programs; Co-Cha
Associate Professor of Neurology, Harvard Medical School
Learning Objectives: At the conclusion of this educational program, learners will be able to:
- Identify sources of excess mortality and morbidity in COVID-19 infections in the US
- Recognize common and less common neurologic consequences of COVID-19 infections in children
- Recognize common and less common cognitive and psychologic consequences of COVID-19 infections in children
In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
David Urion, MD, FAAN: None